POTASSIUM PHOSPHATE MONOBASIC - 搜索结果

potassium phosphate inj 3mmp/ml solution

hospira healthcare ulc - potassium phosphate monobasic; potassium phosphate dibasic - solution - 224mg; 236mg - potassium phosphate monobasic 224mg; potassium phosphate dibasic 236mg - replacement preparations

加拿大 - 英文 - Health Canada

potassium phosphate monobasic injection solution

sandoz canada incorporated - potassium phosphate monobasic - solution - 176mg - potassium phosphate monobasic 176mg - replacement preparations

美国 - 英文 - NLM (National Library of Medicine)

potassium phosphates injection, solution potassium phosphates- potassium phosphate, monobasic potassium phosphate, dibasic inje

american regent, inc. - potassium phosphate, monobasic (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr), potassium phosphate, dibasic (unii: ci71s98n1z) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr) - potassium phosphates injection is indicated as a source of phosphorus: - in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. - for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. potassium phosphates injection is contraindicated in patients with: - hyperkalemia [see warning and precautions (5.3)] - hyperphosphatemia [see warning and precautions (5.4)] - hypercalcemia or significant hypocalcemia [see warning and precautions (5.4)] - severe renal impairment (egfr less than 30 ml/min/1.73m2 ) or end stage renal disease [see warning and precautions (5.3)] risk summary administration of the recommended dose of potassium phosphates injection is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with potassium phosphates inj

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

potassium phosphate concentrate (rem)

paragon care group new zealand limited - dibasic potassium phosphate 2 meq/ml; monobasic potassium phosphate 2 meq/ml - solution for infusion - 2 meq/ml - active: dibasic potassium phosphate 2 meq/ml monobasic potassium phosphate 2 meq/ml

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

potassium phosphate monobasic

jurox pty limited - potassium phosphate monobasic - unknown - potassium phosphate monobasic mineral-potassium active 0.0 - active constituent

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

monobasic potassium phosphate

abbey laboratories pty ltd - potassium phosphate monobasic - unknown - potassium phosphate monobasic mineral-potassium active 0.0 - active constituent

加拿大 - 英文 - Health Canada

artisial liquid

jouveinal inc. - potassium phosphate dibasic; potassium phosphate monobasic; calcium chloride; potassium chloride; sodium chloride; magnesium chloride - liquid - 80.3mg; 32.6mg; 16.625mg; 62.45mg; 86.55mg; 5.875mg - potassium phosphate dibasic 80.3mg; potassium phosphate monobasic 32.6mg; calcium chloride 16.625mg; potassium chloride 62.45mg; sodium chloride 86.55mg; magnesium chloride 5.875mg - eent drugs, miscellaneous

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

phosphate phebra

phebra pty ltd - monobasic sodium phosphate, quantity: 1.936 g - tablet, effervescent - excipient ingredients: potassium bicarbonate; citric acid; sucrose; macrogol 4000; saccharin sodium; sodium bicarbonate; flavour - 1) hypercalcaemia associated with such conditions as hyperparathyroidism, multiple myelomatosis, and metastatic bone disease.,2) hypophosphataemia associated with vitamin d resistant rickets.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dbl potassium dihydrogen phosphate concentrated injection 1.361g/10ml

pfizer australia pty ltd - monobasic potassium phosphate, quantity: 136.1 mg/ml - injection, concentrated - excipient ingredients: water for injections - treatment of severe hypophosphataemia (serum levels less than 0.3 mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. the cause of hypophosphataemia should be identified and treated.

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vytrate liquid concentrate